$Successful treatment of refractory childhood vesiculobullous disorders with rituximab: A study of five cases$

Successful treatment of refractory childhood vesiculobullous disorders with rituximab: A study of five cases

Introduction: Rituximab, a chimeric monoclonal anti-CD20 antibody, has shown efficacy as an adjuvant in the treatment with refractory vesiculobullous disorders. We, hereby, present a study of five pediatric patients of extensive vesiculobullous disorders showing resistance to conventional therapy of...

Full description

Bibliographic Details
Main Authors:	Jeta Y Buch, Ranjan C Raval
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2016-01-01
Series:	Indian Journal of Paediatric Dermatology
Subjects:	Rituximab pediatric vesiculobullous disorders
Online Access:	http://www.ijpd.in/article.asp?issn=2319-7250;year=2016;volume=17;issue=2;spage=104;epage=107;aulast=Buch

Similar Items

A Cross-sectional Study of Clinical, Histopathological and Direct Immunofluorescence Spectrum of Vesiculobullous Disorders
by: Arundhathi S., et al.
Published: (2013-12-01)

Oral bullous pemphigoid – a rarity among vesiculobullous lesions
by: P Venkatalakshmi Aparna, et al.
Published: (2018-01-01)

Anti CD20 (Rituximab) therapy in refractory pediatric rheumatic diseases
by: Joel Reis, et al.
Published: (2016-01-01)

Vesiculobullous autoimmune diseases with oral mucosa manifestations: retrospective and follow-up study
by: Rani Iani Costa GONÇALO, et al.
Published: (2018-03-01)

Successful treatment with rituximab of refractory immune thrombocytopenic purpura
by: Daniela Tirotta, et al.
Published: (2009-12-01)

Successful treatment of refractory adult onset Still’s disease with rituximab
by: N. Belfeki, et al.
Published: (2016-12-01)

A cross-sectional study of direct immunofluorescence in the diagnosis of immunobullous dermatoses
by: Archana C Buch, et al.
Published: (2014-01-01)

Successful Corticosteroid-Sparing Effect of Rituximab in the Treatment of Refractory Idiopathic Orbital Inflammatory Disease
by: Emily H. Shao, et al.
Published: (2013-11-01)

Successful Treatment of a Bullous Pemphigoid Patient with Rituximab Who Was Refractory to Corticosteroid and Omalizumab Treatments
by: Aslı Bilgiç Temel, et al.
Published: (2017-02-01)

Rituximabe na síndrome de Felty refratária Rituximab in the refractory Felty's syndrome
by: Thiago Sotero Fragoso, et al.
Published: (2009-04-01)

Successful use of combined corticosteroids and rituximab in a patient with refractory cutaneous polyarteritis nodosa
by: Ibrahim A. Al-Homood, et al.
Published: (2017-01-01)

Rituximab Use in the Management of Childhood Nephrotic Syndrome
by: Mahmoud Kallash, et al.
Published: (2019-05-01)

Successful implementation of rituximab in patients with severe refractory forms granulomatosis with poliangiitis
by: Bolpačić Jasna, et al.
Published: (2018-01-01)

Refractory myasthenia gravis – clinical profile, comorbidities and response to rituximab
by: Sudulagunta, Sreenivasa Rao, et al.
Published: (2016-10-01)

Bullous Pemphigoid Successfully Treated with Rituximab
by: Nuno Silva, et al.
Published: (2017-03-01)

Successful treatment of IgG4‐related hypertrophic pachymeningitis with induction rituximab and dexamethasone followed by maintenance rituximab
by: Karan Seegobin, et al.
Published: (2021-03-01)

Favorable rituximab response in patients with refractory idiopathic inflammatory myopathies
by: Fernando Henrique Carlos de Souza, et al.
Published: (2018-09-01)

A study of the prevalence of methicillin-resistant Staphylococcus aureus in dermatology inpatients
by: N Vijayamohan, et al.
Published: (2014-01-01)

Linear IgA bullous dermatosis: report of an exuberant clinical case and literature review
by: Sandra Pereira, et al.
Published: (2019-01-01)

Rituximab Therapy for Severe Cutaneous Leukocytoclastic Angiitis Refractory to Corticosteroids, Cellcept and Cyclophosphamide
by: Kamel El-Reshaid, et al.
Published: (2013-04-01)

Successful treatment of a patient with refractory immune thrombocytopenic purpura in systemic lupus erythematosus with rituximab
by: Kazuya Abe, et al.
Published: (2019-10-01)

Childhood Stiff-Person Syndrome Improved with Rituximab
by: R. Fekete, et al.
Published: (2012-05-01)

Acquired Hemophilia A successfully treated with rituximab
by: Giovanni D'Arena, et al.
Published: (2015-02-01)

Intravenous Rituximab in Severe Refractory Primary Focal Segmental Glomerulosclerosis
by: Wee Leng Gan, et al.
Published: (2018-10-01)

Pregnancy outcome in patients with neuromyelitis optica spectrum disorder treated with rituximab: A case-series study
by: Maral Seyed Ahadi, et al.
Published: (2021-07-01)

Hailey-Hailey Disease: An Uncommon Cause of Recurrent Axillary Sinuses
by: Nadia Shirazi, et al.
Published: (2017-05-01)

Pênfigo foliáceo endêmico refratário na adolescência: sucesso terapêutico com imunoglobulina intravenosa Refractory endemic pemphigus foliaceous in adolescence successfully treated with intravenous immunoglobulin
by: Talita Alves Teixeira, et al.
Published: (2011-08-01)

Chronotherapy in the treatment of oral pemphigus vulgaris: A case report
by: Mandavi Waghmare, et al.
Published: (2021-01-01)

Rituximab in relapsed/refractory antineutrophil cytoplasmic antibody associated vasculitis: A single-center prospective observational study
by: Ekbote Gayatri, et al.
Published: (2019-01-01)

Rituximab: historia, farmacología y perspectivas Rituximab: history, pharmacology and perspectives
by: Edgardo E. Espinosa Estrada, et al.
Published: (2010-12-01)

Lenalidomide plus rituximab Vs rituximab alone in relapsed or refractory indolent lymphoma: A cost‐effectiveness analysis
by: Peng‐Fei Zhang, et al.
Published: (2020-08-01)

Macroglobulinemia de Waldenström - remissão completa após tratamento com rituximabe Successful outcome in Waldenström's macroglobulinemia treated with rituximab
by: Flavia C. F. Pimenta, et al.
Published: (2008-10-01)

Consciousness Recovery by Rituximab after Seizure Control in Cryptogenic New-Onset Refractory Status Epilepticus
by: Tae-Won Yang, et al.
Published: (2018-12-01)

Novel applications of Rituximab in dermatological disorders
by: Prasan R Bhandari, et al.
Published: (2014-01-01)

Rituximab Twice Weekly for Refractory Thrombotic Thrombocytopenic Purpura in a Critically Ill Patient with Acute Respiratory Distress Syndrome
by: Bahjat Azrieh, et al.
Published: (2020-02-01)

Long-term repeated rituximab treatment for childhood steroid-dependent nephrotic syndrome
by: Ji Hyun Kim, et al.
Published: (2017-09-01)

Remission of Refractory Membranous Nephropathy by Low-dose Rituximab: A Case Report
by: Xiao-Pei Wang, et al.
Published: (2016-01-01)

Pemphigus vulgaris successfully treated with ocrelizumab following rituximab allergy
by: Gabrielle Benesh, BS, et al.
Published: (2021-10-01)

A comparative study of expression of Fc receptors in relation to the autoantibody-mediated immune response and neutrophil elastase expression in autoimmune blistering dermatoses
by: Justyna Gornowicz-Porowska, et al.
Published: (2017-09-01)

Oral pemphigus vulgaris in a pediatric patient
by: Anand R, et al.
Published: (2010-09-01)

Cannot write session to /tmp/vufind_sessions/sess_ed06la41b47le3tfvajgd4bd29